Financings Roundup
Corcept Therapeutics Inc., of Menlo Park, Calif., disclosed plans for an underwritten public offering of 11 million shares of common stock.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.